HMedical ResearchEIN: 822120760· Ruling Year: 2018

Odylia Therapeutics Inc

Atlanta, Georgia

B-Health Score
47B-

Financial Health Score

8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.

Average

💰
$571K
Total Revenue
📊
$867K
Total Expenses
🏦
$9.6M
Net Assets
📋
$41K
Total Liabilities

Financial Trends

5-Year Trend Analysis

Financial Health Indicators

Revenue Growth
-48.0%
Year-over-year change (2022 → 2023)
Net Margin
-51.9%
Revenue minus expenses as % of revenue
Working Capital Ratio
11.12
Net assets divided by total expenses
Liabilities-to-Assets
0.4%
Total liabilities as % of total assets

Filing History

6 filings on record
YearRevenueExpensesAssets
2023$570,77348%$867,236$9,688,6443%
2022$1,098,401220%$866,47374%$10,021,6512%
2021$343,480467%$498,2718%$9,833,1911%
2020$60,52895%$460,91069%$9,953,1343%
2019$1,275,84794%$1,465,742693%$10,288,47050%
2018$20,657,445$184,728$20,473,217

Frequently Asked Questions

What does Odylia Therapeutics Inc do?

Odylia Therapeutics Inc is a medical research nonprofit organization based in Georgia. It is classified under NTEE code H41 and is registered as a 501(c) tax-exempt organization with the IRS.

Is Odylia Therapeutics Inc financially healthy?

Financial health scoring requires Form 990 filing data. Check back as we process more filings for Odylia Therapeutics Inc.

How much revenue does Odylia Therapeutics Inc generate?

Odylia Therapeutics Inc reports $482K in annual revenue and holds $1.6M in total assets, based on IRS filings.

Similar Organizations

Explore more organizations in the Medical Research category, or browse all nonprofits in Georgia.